Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
The Indian Journal of Medical Research|July 1, 1992
Serum beta 2 microglobulin levels in HIV seropositive personsM Thakar, J Rodrigues, N Athalye, et al.Expert Opinion on Biological Therapy|July 24, 2020
Itolizumab, an anti-CD6 monoclonal antibody, as a potential treatment for COVID-19 complicationsSubramanian Loganathan, Sandeep N Athalye, Shashank R JoshiVox Sanguinis|January 1, 1989
Screening for AIDS in western India: transfusion aspectsJ J Rodrigues, Z R Israel, N Athalye, et al.Drugs|August 14, 2023
Insulin Tregopil: An Ultra-Fast Oral Recombinant Human Insulin Analog: Preclinical and Clinical Development in Diabetes MellitusShashank Joshi, Vathsala Jayanth, Subramanian Loganathan, et al.Expert Opinion on Biological Therapy|August 22, 2022
Biosimilars and interchangeable biosimilars: facts every prescriber, payor, and patient should know. Insulins perspectiveShashank R Joshi, Shivani Mittra, Praveen Raj, et al.Clinical and Translational Science|December 29, 2018
Impact of Insulin Tregopil and Its Permeation Enhancer on Pharmacokinetics of Metformin in Healthy Volunteers: Randomized, Open-Label, Placebo-Controlled, Crossover StudyAnand Khedkar, Harold Lebovitz, Alexander Fleming, et al.Clinical Pharmacology in Drug Development|August 9, 2019
Pharmacokinetics and Pharmacodynamics of Insulin Tregopil in Relation to Premeal Dosing Time, Between Meal Interval, and Meal Composition in Patients With Type 2 Diabetes MellitusAnand Khedkar, Harold Lebovitz, Alexander Fleming, et al.Expert Opinion on Biological Therapy|June 27, 2024
Comparison of the efficacy and safety of rapid-acting insulin analogs, lispro versus aspart, in the treatment of diabetes: a systematic review of randomized controlled trialsRahul Kapur, Shivani Mittra, Geetanjali Tonpe, et al.Diabetes, Obesity & Metabolism|February 7, 2023
Comparative clinical efficacy and safety of insulin glargine 300 U/ml (Toujeo) versus insulin glargine 100 U/ml in type 2 diabetes and type 1 diabetes: A systematic literature review and meta-analysisShashank R Joshi, Gursharan Singh, Ashwani Marwah, et al.Diabetes, Obesity & Metabolism|January 4, 2022
Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar Insulin-R with the US-licensed Humulin® R formulation in healthy subjects: Results from the RHINE-1 (Recombinant Human INsulin Equivalence-1) studyLeona Plum-Mörschel, Gursharan Singh, Sundara Moorthi Nainar Murugesan, et al.Pageof 2